Skip to main content
Signal8

LaBarre Michael J.

SEC insider (Form 3/4/5 filer). CIK 0001507174. SVP, CHIEF TECHNICAL OFFICER at HALOZYME THERAPEUTICS, INC. (HALO). 33 reported Form 4/5 transactions since Sep 2024; latest on Feb 27, 2025. Located in SAN DIEGO, CA.

Companies LaBarre Michael J. has filed insider reports for

  • HALOZYME THERAPEUTICS, INC. (HALO): Officer, SVP, CHIEF TECHNICAL OFFICER
LaBarre Michael J. profile photo

LaBarre Michael J.

CIK: 0001507174

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)12 (36.4%)

Position reduction

Option Exercises (M)10 (30.3%)

Derivative conversions

Awards (A)6 (18.2%)

Compensation grants

Other (G, F, J, C, D, …)5 (15.2%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

HALOZYME THERAPEUTICS, INC. logo
HALO

HALOZYME THERAPEUTICS, INC.

Officer

Discretionary Trading P&L

Holdings

Transaction History (33 total)

  • HALOZYME THERAPEUTICS, INC. logo
    HALO

    HALOZYME THERAPEUTICS, INC.

    Feb 27, 2025
    Sale
    Direct
    1.6K shares at avg. $58.25$93K
  • HALOZYME THERAPEUTICS, INC. logo
    HALO

    HALOZYME THERAPEUTICS, INC.

    Feb 27, 2025
    Sale
    Direct
    100 shares at avg. $58.74$6K
  • HALOZYME THERAPEUTICS, INC. logo
    HALO

    HALOZYME THERAPEUTICS, INC.

    Feb 26, 2025
    Sale
    Direct
    600 shares at avg. $58.65$35K
  • HALOZYME THERAPEUTICS, INC. logo
    HALO

    HALOZYME THERAPEUTICS, INC.

    Feb 26, 2025
    Sale
    Direct
    9.4K shares at avg. $58.09$546K
  • HALOZYME THERAPEUTICS, INC. logo
    HALO

    HALOZYME THERAPEUTICS, INC.

    Feb 25, 2025
    Sale
    Direct
    9.3K shares at avg. $58.01$539K
  • HALOZYME THERAPEUTICS, INC. logo
    HALO

    HALOZYME THERAPEUTICS, INC.

    Feb 25, 2025
    Sale
    Direct
    700 shares at avg. $58.67$41K
  • HALOZYME THERAPEUTICS, INC. logo
    HALO

    HALOZYME THERAPEUTICS, INC.

    Feb 23, 2025
    Tax Payment
    Direct
    2.4K shares at avg. $57.75$139K
  • HALOZYME THERAPEUTICS, INC. logo
    HALO

    HALOZYME THERAPEUTICS, INC.

    Feb 23, 2025
    Exercise
    Direct
    4.7K shares-
  • HALOZYME THERAPEUTICS, INC. logo
    HALO

    HALOZYME THERAPEUTICS, INC.

    Feb 20, 2025
    Award

    Option to Purchase Common Stock

    Direct
    11.9K shares-
  • HALOZYME THERAPEUTICS, INC. logo
    HALO

    HALOZYME THERAPEUTICS, INC.

    Feb 20, 2025
    Award

    Restricted Stock Units

    Direct
    11.2K shares-

1-10 of 33